956
Participants
Start Date
August 19, 2014
Primary Completion Date
September 6, 2017
Study Completion Date
September 6, 2017
Isoniazid (INH)
300-mg tablet once daily by mouth, either from entry through Week 28 antepartum (Arm A) or from Week 12 postpartum through Week 40 postpartum (Arm B)
Placebo for isoniazid (INH)
Placebo tablet once daily by mouth, either from Week 28 visit through Week 40 postpartum (Arm A) or from entry until Week 12 postpartum visit (Arm B)
Soweto IMPAACT CRS, Johannesburg
Desmond Tutu TB Centre - Stellenbosch University (DTTC-SU) CRS, Cape Town
Fam-Cru Crs, Cape Town
Chiang Mai University HIV Treatment (CMU HIV Treatment) CRS, Chiang Mai
Byramjee Jeejeebhoy Medical College (BJMC) CRS, Pune
Gaborone CRS, Gaborone
Molepolole CRS, Gaborone
Kilimanjaro Christian Medical Centre (KCMC), Moshi
MU-JHU Research Collaboration (MUJHU CARE LTD) CRS, Kampala
Seke North CRS, Chitungwiza
St Mary's CRS, Chitungwiza
Harare Family Care CRS, Harare
Les Centres GHESKIO Clinical Research Site (GHESKIO-INLR) CRS, Port-au-Prince
National Institute of Allergy and Infectious Diseases (NIAID)
NIH